Matches in Nanopublications for { ?s ?p "[Combined genetic and transcriptional analyses showed consistent overexpression of GATA-6 in all carcinomas with 18q11.2 gain, as well as in the majority of pancreatic cancers examined (17 of 30 cancers, 56.7%) that did not have gain of this region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP635315.RABC8FiZntWM-ujfgC9YZR4y96SCUZhH1i7DaWvhUexKo130_assertion description "[Combined genetic and transcriptional analyses showed consistent overexpression of GATA-6 in all carcinomas with 18q11.2 gain, as well as in the majority of pancreatic cancers examined (17 of 30 cancers, 56.7%) that did not have gain of this region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635315.RABC8FiZntWM-ujfgC9YZR4y96SCUZhH1i7DaWvhUexKo130_provenance.
- assertion description "[Combined genetic and transcriptional analyses showed consistent overexpression of GATA-6 in all carcinomas with 18q11.2 gain, as well as in the majority of pancreatic cancers examined (17 of 30 cancers, 56.7%) that did not have gain of this region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP925489.RAyGVdaE2ldigRwP-aRpuOZ1yL8kSgAzEXbtDBJ2Lp_S4130_assertion description "[Combined genetic and transcriptional analyses showed consistent overexpression of GATA-6 in all carcinomas with 18q11.2 gain, as well as in the majority of pancreatic cancers examined (17 of 30 cancers, 56.7%) that did not have gain of this region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925489.RAyGVdaE2ldigRwP-aRpuOZ1yL8kSgAzEXbtDBJ2Lp_S4130_provenance.
- NP614391.RAJ5GZDb20wbJvYOKokDlZCFUeXpYSay9MyLXf6xrAsSY130_assertion description "[Combined genetic and transcriptional analyses showed consistent overexpression of GATA-6 in all carcinomas with 18q11.2 gain, as well as in the majority of pancreatic cancers examined (17 of 30 cancers, 56.7%) that did not have gain of this region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614391.RAJ5GZDb20wbJvYOKokDlZCFUeXpYSay9MyLXf6xrAsSY130_provenance.
- NP691388.RARqvGDwt9_g4GNRiA4awU2vKIs0Ny7rXLfHgNct-0pCY130_assertion description "[Combined genetic and transcriptional analyses showed consistent overexpression of GATA-6 in all carcinomas with 18q11.2 gain, as well as in the majority of pancreatic cancers examined (17 of 30 cancers, 56.7%) that did not have gain of this region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691388.RARqvGDwt9_g4GNRiA4awU2vKIs0Ny7rXLfHgNct-0pCY130_provenance.
- NP419662.RAjNbwC9z5-rYH4GJGxj_N82KxmL2hqitg9tkI4t4Vuro130_assertion description "[Combined genetic and transcriptional analyses showed consistent overexpression of GATA-6 in all carcinomas with 18q11.2 gain, as well as in the majority of pancreatic cancers examined (17 of 30 cancers, 56.7%) that did not have gain of this region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419662.RAjNbwC9z5-rYH4GJGxj_N82KxmL2hqitg9tkI4t4Vuro130_provenance.
- NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_assertion description "[Combined genetic and transcriptional analyses showed consistent overexpression of GATA-6 in all carcinomas with 18q11.2 gain, as well as in the majority of pancreatic cancers examined (17 of 30 cancers, 56.7%) that did not have gain of this region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419759.RAt4yLgv6XlsR_1gdLKayM4J0gACvi9B4B5oNwUk5ICHY130_provenance.